Trial Profile
Pharmacokinetics, Tolerability, Immunogenicity, Dose increasing safety and Evaluate of preliminary effect clinical trial on GR1501 injection in patients with plaque psoriasis
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs Xeligekimab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors Genrix (Shanghai) Biopharmaceuticals
- 31 Aug 2018 New trial record